CVS To Pay $36.5M To Settle States' Insulin FCA Suits
CVS has agreed to shell out $36.5 million to put to rest a handful of False Claims Act suits from states and the federal government, which allege the pharmacy chain submitted...To view the full article, register now.
Already a subscriber? Click here to view full article